These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10900502)

  • 1. [Induction of anti-meningitis immunity using the synthetic peptides. I. The immunoreactive synthetic fragments of porin A from Neisseria meningitidis].
    Koroev DO; Kotel'nikova OV; Vol'pina OM; Zhmak MN; Kupriianova MA; Agafonova SA; Alliluev AP; Litvinov IS; Nesmeianov VA; Ivanov VT
    Bioorg Khim; 2000 May; 26(5):323-9. PubMed ID: 10900502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Induction of the anti-meningitis immunity with synthetic peptides. III. Immunoactive synthetic fragments of NspA protein from Neisseria meningitidis].
    Koroev DO; Oboznaia MB; Zhmak MN; Volkova TD; Titova MA; Kotel'nikova OV; Lakhtina OE; Vol'pina OM; Nesmeianov VA; Alliluev AP; Ivanov VT
    Bioorg Khim; 2002; 28(4):291-7. PubMed ID: 12197384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-PorA antibodies elicited by immunization with peptides conjugated to P64k.
    Sardiñas G; González S; Garay HE; Nazábal C; Reyes O; Silva R
    Biochem Biophys Res Commun; 2000 Oct; 277(1):51-4. PubMed ID: 11027638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 5. Thermodynamic analysis of the interaction between a bactericidal antibody and a PorA epitope of Neisseria meningitidis.
    van den Elsen JM; van Unen LM; van Bloois L; Busquets MA; Jiskoot W; Hoogerhout P; Wilting J; Herron JN; Crommelin DJ
    Biochemistry; 1997 Oct; 36(41):12583-91. PubMed ID: 9376364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide.
    Christodoulides M; McGuinness BT; Heckels JE
    J Gen Microbiol; 1993 Aug; 139(8):1729-38. PubMed ID: 7691983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous production of the P1 porin of Neisseria meningitidis in bacillus subtilis: the effect of an N-terminal extension on the presentation of native-like epitopes.
    Muttilainen S; Butcher SJ; Runeberg K; Nurminen M; Idänpään-Heikkilä I; Wahlström E; Sarvas M
    Microb Pathog; 1995 May; 18(5):365-71. PubMed ID: 7476101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivalent liposome-based vaccines containing different serosubtypes of PorA protein induce cross-protective bactericidal immune responses against Neisseria meningitidis.
    Humphries HE; Williams JN; Blackstone R; Jolley KA; Yuen HM; Christodoulides M; Heckels JE
    Vaccine; 2006 Jan; 24(1):36-44. PubMed ID: 16105711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vaccines against Neisseria meningitidis].
    Ferrón L; Criado MT; Ferreirós CM
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):296-301. PubMed ID: 1391002
    [No Abstract]   [Full Text] [Related]  

  • 10. Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines.
    Heyderman RS; Davenport V; Williams NA
    Trends Microbiol; 2006 Mar; 14(3):120-4. PubMed ID: 16469496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease.
    Litt DJ; Savino S; Beddek A; Comanducci M; Sandiford C; Stevens J; Levin M; Ison C; Pizza M; Rappuoli R; Kroll JS
    J Infect Dis; 2004 Oct; 190(8):1488-97. PubMed ID: 15378443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide.
    van den Elsen JM; Herron JN; Hoogerhout P; Poolman JT; Boel E; Logtenberg T; Wilting J; Crommelin DJ; Kroon J; Gros P
    Proteins; 1997 Sep; 29(1):113-25. PubMed ID: 9294871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term monitoring of Neisseria meningitidis carrier state in the nasopharynx and seroprevalence of specific antibodies in immunized and non-immunized persons].
    Kartusek S; Douda P; Gál P; Koudelková M; Marková Z; Krízová P; Musílek M
    Epidemiol Mikrobiol Imunol; 1998 Dec; 47(4):145-9. PubMed ID: 9919815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with a multiple antigen peptide containing defined B- and T-cell epitopes: production of bactericidal antibodies against group B Neisseria meningitidis.
    Christodoulides M; Heckels JE
    Microbiology (Reading); 1994 Nov; 140 ( Pt 11)():2951-60. PubMed ID: 7529096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope specificity of murine and human bactericidal antibodies against PorA P1.7,16 induced with experimental meningococcal group B vaccines.
    Rouppe van der Voort EM; Kuipers B; Brugghe HF; van Unen LM; Timmermans HA; Hoogerhout P; Poolman JT
    FEMS Immunol Med Microbiol; 1997 Mar; 17(3):139-48. PubMed ID: 9093834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, sequencing and expression of immunoglobulin variable regions of murine monoclonal antibodies specific for the P1.7 and P1.16 PorA protein loops of Neisseria meningitidis.
    Ihle Ø; Beckstrøm KJ; Michaelsen TE
    Scand J Immunol; 2003 May; 57(5):453-62. PubMed ID: 12753502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.
    Prinz DM; Smithson SL; Westerink MA
    J Immunol Methods; 2004 Feb; 285(1):1-14. PubMed ID: 14871530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of in vitro folded outer membrane protein PorA of Neisseria meningitidis.
    Jansen C; Kuipers B; van der Biezen J; de Cock H; van der Ley P; Tommassen J
    FEMS Immunol Med Microbiol; 2000 Mar; 27(3):227-33. PubMed ID: 10683467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma fibrinogen levels after vaccination with a native outer membrane vesicle vaccine for Neisseria meningitidis.
    Keiser PB; Miller LB; Biggs-Cicatelli S; Zollinger WD
    Vaccine; 2009 Nov; 27(49):6809-13. PubMed ID: 19761833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable region.
    Kortekaas J; Pettersson A; van der Biezen J; Weynants VE; van der Ley P; Poolman J; Bos MP; Tommassen J
    Vaccine; 2007 Jan; 25(1):72-84. PubMed ID: 16914236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.